GUIDE.MRD Webinar on
Understanding The System: Adoption of Innovative Diagnostics in Oncology Care
Session Description:
Integrating innovative diagnostics into routine oncology care has the potential to improve how cancer is monitored after treatment—helping clinicians detect early signs of relapse, tailor follow-up care, and avoid unnecessary interventions. However, whether and how these tests reach patients in practice depends on a complex healthcare system involving many actors, decisions, and constraints that are not always visible or well understood.
One such innovation is circulating tumor DNA (ctDNA) tests, which are used in detecting tiny fragments of cancer cells in the bloodstream, also known as Minimal Residual Disease (MRD). The GUIDE.MRD project is validating this technology in lung, pancreatic, and colorectal cancer. Through co-creation with nearly 200 stakeholders, the GUIDE.MRD project consortium developed a system map to understand how the ctDNA MRD system operates, the roles different stakeholders play along the way, and the key barriers and enabling factors that shape the adoption of ctDNA tests.
This webinar shares some learnings from the system map exercise and invites a broader audience to reflect on whether they resonate with their lived realities. By bringing together diverse perspectives and expertise from across the system, the session aims to exchange learnings and gather real-world insights that will inform the project’s next phase of work to understand conditions that unlock system change and improve patient outcomes.
What you can expect:
- Understand from a system-wide perspective, the dynamics & factors influencing the adoption of ctDNA MRD testing in the healthcare system.
- Understand how your role fits within the system and how you could influence system change.
- Share your perspectives on system change needs and how stakeholders could work or are already working to address them.
We invite you to explore the key learnings from the GUIDE.MRD System Map ahead of the webinar, so you can join the conversation fully prepared to share any thoughts and questions you may have.
